Vitamin K2 Market Size, Share, Trends, Industry Analysis Report: By Product Type (MK-4 & Combination Drugs and MK-7 Drugs), Source, Form, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025 –20

Vitamin K2 Market Size, Share, Trends, Industry Analysis Report: By Product Type (MK-4 & Combination Drugs and MK-7 Drugs), Source, Form, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025 –2034

The global vitamin K2 market size is expected to reach USD 145.62 billion by 2034, according to a new study by Polaris Market Research. The report “Vitamin K2 Market Size, Share, Trends, Industry Analysis Report: By Product Type (MK-4 & Combination Drugs and MK-7 Drugs), Source, Form, Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing awareness of its health benefits, particularly in bone and cardiovascular health, propels the vitamin K2 market growth. Key drivers include the rising prevalence of osteoporosis and heart disease, coupled with an aging global population that is more susceptible to these conditions. Consumers are increasingly turning to vitamin K2 supplements and functional foods as preventive health measures, boosting demand. Opportunities exist in the growing preference for natural and plant-based vitamin K2, sourced from fermented foods such as natto.

Vitamin K2 market trends such as the rise of functional foods, the shift toward preventive healthcare, and technological advancements in product formulation are further shaping the market. As awareness continues to expand and the demand for effective, bioavailable vitamin K2 products rises, the market is poised for continued growth across various regions, particularly in North America, Europe, and the Asia Pacific.

Vitamin K2 Market Report Highlights

Based on product type, the MK-7 drugs segment dominates the vitamin K2 market share due to their superior bioavailability and longer half-life, making them the preferred choice in dietary supplements for bone and cardiovascular health. The MK-4 & combination drugs segment is also growing steadily, especially in the pharmaceutical sector for treating osteoporosis and other specific health conditions.

By source, the natural segment leads the vitamin K2 market revenue share, driven by consumer preference for organic and plant-based vitamin K2, particularly from fermented foods such as natto. This segment is expanding rapidly as more consumers prioritize natural, non-synthetic ingredients in their health products.

Capsules & tablets are the most widely used form due to their convenience, accurate dosage, and long shelf life, making them the dominant segment in the market. However, the powder segment is registering the highest growth, particularly in functional foods and beverages, where it offers versatility for fortified products.

By application, the food & pharmaceutical segment holds the largest share, with vitamin K2 being heavily used in dietary supplements and pharmaceutical products for bone and heart health. The nutraceutical sector is growing the fastest as more consumers shift toward preventive health and natural supplements.

North America holds the largest market share, driven by high demand for dietary supplements and functional foods. However, Asia Pacific is the fastest-growing region, fueled by increasing health awareness, rising middle-class population, and the traditional use of fermented foods rich in vitamin K2.

Polaris Market Research has segmented the vitamin K2 market report on the basis of product type, source, form, application, and region

By Product Type Outlook (Revenue – USD Billion, 2020–2034)

MK-4 & Combination Drugs

MK-7 Drugs

By Source Outlook (Revenue – USD Billion, 2020–2034)

Natural

Synthetic

By Form Outlook (Revenue – USD Billion, 2020–2034)

Capsules & Tablets

Powder

Oil

By Application Outlook (Revenue – USD Billion, 2020–2034)

Food & Pharmaceutical

Nutraceutical

By Regional Outlook (Revenue – USD Billion, 2020–2034)

North America

• US
• Canada

Europe

• Germany
• France
• UK
• Italy
• Spain
• Netherlands
• Russia
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Malaysia
• South Korea
• Indonesia
• Australia
• Vietnam
• Rest of Asia Pacific

Middle East & Africa

• Saudi Arabia
• UAE
• Israel
• South Africa
• Rest of Middle East & Africa

Latin America

• Mexico
• Brazil
• Argentina
• Rest of Latin America